Niagen Bioscience, Inc. Common Stock(NAGE)

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

Snapshot
$3.41
52-Week Range
$3.29 – $14.69
YTD
-45.44%
IV Rank (30D)
31.82
Straddle Price
$1.40
P/C Vol Ratio
0.18
Market Cap
$0.3B
Fair Value
+27.5% vs price
Confidence: 64% Alpha Score: 0.37

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 0.5% and dividend payments are stable.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.50%
Beta vs SPY1.00
Cost of Equity (CAPM)10.00% (VRP-adj)
WACC10.08%
Volatility Risk Premium+126.7pp (IV − HV30), ERP adj +50bps
Effective Tax Rate5.4%
Rev. Growth (YoY, DCF input)+1.1%
DCF Horizon10 years explicit + fade
Forward Tilt (NTM/TTM)×1.01 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$0.0B
Return on Equity (TTM)22.6%
Book / Price29.0%
Gross Margin (TTM)64.3%
FCF Margin (TTM)3.1%
Debt / Equity0.00
Quality Score3/6 — normal (10y DCF)
Market-Implied Growth+26.8% (reverse-DCF on current price)
SMA 50$4.02 (Market Anchor value)
SMA 20 / Bollinger Mid$3.49
Bollinger Width / SMA20447.6% (drives anchor stability)
Net Debt$-0.1B
Market Cap$0B
Peers used for multiples: ACRS, ALKS, CCCC, COST, CYRX, IART, WMT, XOMA
Blended Fair Value
$4.36
Current Price
$3.42
Deviation
+27.5%
Forward-Return Rank LONG gates ✓
?
Horizon Expected α z Pred Blended z Rank % Active?
21d -5.2% -0.79 -0.15 17.2%
42d -5.8% -0.16 +0.16 31.6%
63d -5.0% +0.22 +0.35 37.1%
Expected α = forward-return point estimate vs SPY (e.g., +7.5% means the predictor expects this stock to outperform SPY by 7.5% over that horizon). For SHORT direction the model uses a different ranking metric (conviction-weighted deviation, not the LGBM prediction); Expected α is shown for reference. flags rows where Expected α disagrees with the FV direction — two independent signals are in conflict; conviction is low even if rank looks extreme.
Forward-Return Rank. A proprietary ensemble of a machine-learning forward-return model and a conviction-weighted fundamental score, ranked cross-sectionally each day across the S&P 500 (and broader universes on the screener). Each stock is scored at three horizons (21/42/63 trading days). "Active" = top/bottom 5% AND all risk filters pass. Backtested mean alpha vs SPY on active picks: 21d LONG +13.4%, 63d +34.9% (S&P 500, walk-forward). Past performance is not indicative of future results.
Value vs momentum conflict ⚠. The "FV direction" (long/short) comes from the fundamentals-based engine — price vs intrinsic value. The "Expected α" comes from a separate machine-learning predictor trained on ~12 features (sector, options-implied move, beta, institutional flow, etc.). Sometimes the two disagree: a stock is overvalued by fundamentals but the predictor expects it to keep outperforming (sector or momentum tailwinds). When all 3 horizons disagree, treat the direction signal as low-conviction — neither model is strongly recommending a position.
MethodImplied PriceWeightDetail
DCF $1.38 26%
DDM (Gordon) n/a 0%
Peer P/E $8.85 12% median 41.6× · 5 peers
Peer EV/EBITDA $5.71 12% median 29.9× · 5 peers
Peer P/B $4.49 2% median 4.7× · 8 peers
Peer P/S $7.24 8% median 4.7× · 8 peers
Market Anchor (SMA50) $4.02 40% stability 77% (BB-width)
Options Expected (B-L 30d) n/a 0%
As of 2026-06-26 · updated 2026-06-26 20:59:30.580000
Info
Industry (SIC)
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS (2833)
Exchange
XNAS
Market Cap
$0.3B

Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

Chart
Seasonality
MonthAvg ReturnYears of Data
Jan -6.41% 1
Feb -15.13% 1
Mar -10.20% 2
Apr +15.27% 2
May +9.63% 2
Jun +4.62% 2
Jul -35.07% 1
Aug +1.23% 1
Sep -5.57% 1
Oct -20.29% 1
Nov -10.64% 1
Dec -4.65% 1
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators
SMA 20: $3.47
SMA 50: $3.99
SMA 200: $5.83
Current: $3.42
EMA 12: $3.44
EMA 26: $3.59
MACD: -0.1502 | Signal: 0.0269
BEARISH
ADX (14): 32.78
TREND
+DI: 13.15
−DI: 22.01
Momentum Oscillators
RSI (14): 42.21
NEUTRAL
Stoch %K: 28.64
Stoch %D: 23.91
Williams %R: -59.12
Volume & Volatility
BB Upper: $3.69
BB Lower: $3.25
NEUTRAL
OBV: 2,170,823
Vol SMA 20: 793,616
Vol ROC: 354.06%
ATR: $0.17
True Range: $0.12
HV 20: 44.4%
HV 30: 43.6%
HV 60: 55.4%

Data Summary
Data Points: 320
Last Updated: 2026-06-26T21:15:18.653000
Date Range: 2025-03-19T00:00:00 – 2026-06-26T00:00:00
AI Analysis

Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

News
Earnings History
5 of 5 under expected move
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2025-05-07 Pre-Market 15.98% 3.65% 0.23x Within
2025-08-06 After-Close 18.38% 11.67% 0.63x Within
2025-11-04 After-Close 24.06% 8.02% 0.33x Within
2026-03-04 After-Close 22.98% 4.10% 0.18x Within
2026-05-06 After-Close 14.96% 10.47% 0.70x Within
Options Activity
IV Rank (30D)
31.82
IV Rank (7D)
31.82
Avg IV
159.6%
Straddle (30D)
$1.40
Straddle (7D)
$1.40
P/C Volume
0.18
Spread Scanner GPU

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
pts EXTREME
ATM — / Wing —
30 DTE / 10d
pts EXTREME
ATM — / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Beta (1Y vs SPY)
1.37
Correlation (SPY)
33.8%
0.11
Ann. Volatility
50.4%
SPY Volatility
12.5%

High volatility - stock moves more than market

Beta & Alpha Over Time
Institutional Ownership (13F)
Latest filings — 2026-03-31
Diluted shares outstanding: 85,715,500 (as of 2026-03-31)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

142 filers36,530,563 shares$160.46M value42.62% of float
# Filer Shares Value % of Total % of Float Period
1 VANGUARD GROUP INC Custodian 3,286,498 $20.90M 13.03% 3.83% 2025-12-31
2 BlackRock, Inc. Custodian 3,871,619 $17.07M 10.64% 4.52% 2026-03-31
3 SteelPeak Wealth, LLC 3,373,000 $14.87M 9.27% 3.94% 2026-03-31
4 ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 2,378,437 $10.49M 6.54% 2.77% 2026-03-31
5 Qube Research & Technologies Ltd 1,714,639 $7.56M 4.71% 2.00% 2026-03-31
6 UBS Group AG Custodian 1,405,531 $6.20M 3.86% 1.64% 2026-03-31
7 GEODE CAPITAL MANAGEMENT, LLC Custodian 1,344,921 $5.93M 3.70% 1.57% 2026-03-31
8 RENAISSANCE TECHNOLOGIES LLC 1,328,843 $5.86M 3.65% 1.55% 2026-03-31
9 MORGAN STANLEY Custodian 880,124 $5.60M 3.49% 1.03% 2025-12-31
10 GOLDMAN SACHS GROUP INC Custodian 1,251,959 $5.52M 3.44% 1.46% 2026-03-31
11 STATE STREET CORP 1,084,565 $4.78M 2.98% 1.27% 2026-03-31
12 DIMENSIONAL FUND ADVISORS LP Custodian 1,071,133 $4.72M 2.94% 1.25% 2026-03-31
13 AQR CAPITAL MANAGEMENT LLC Custodian 1,031,335 $4.55M 2.83% 1.20% 2026-03-31
14 SEI INVESTMENTS CO Custodian 971,574 $4.28M 2.67% 1.13% 2026-03-31
15 Connor, Clark & Lunn Investment Management Ltd. 582,448 $2.57M 1.60% 0.68% 2026-03-31
16 Trexquant Investment LP 576,816 $2.54M 1.59% 0.67% 2026-03-31
17 MILLENNIUM MANAGEMENT LLC Custodian 551,349 $2.43M 1.52% 0.64% 2026-03-31
18 CITADEL ADVISORS LLC Custodian 530,477 $2.34M 1.46% 0.62% 2026-03-31
19 LOS ANGELES CAPITAL MANAGEMENT LLC 481,442 $2.12M 1.32% 0.56% 2026-03-31
20 ALLIANCEBERNSTEIN L.P. 322,961 $2.05M 1.28% 0.38% 2026-03-31
21 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 447,359 $1.97M 1.23% 0.52% 2026-03-31
22 VICTORY CAPITAL MANAGEMENT INC 425,422 $1.88M 1.17% 0.50% 2026-03-31
23 NORTHERN TRUST CORP Custodian 396,067 $1.75M 1.09% 0.46% 2026-03-31
24 JPMORGAN CHASE & CO Custodian 326,711 $1.40M 0.87% 0.38% 2026-03-31
25 BANK OF AMERICA CORP /DE/ Custodian 304,718 $1.34M 0.84% 0.36% 2026-03-31
7 filers$924.08K notional
# Filer Notional Value % of Total Period
1 WOLVERINE TRADING, LLC Custodian $308.88K 33.43% 2025-09-30
2 Caption Management, LLC $211.68K 22.91% 2026-03-31
3 SIMPLEX TRADING, LLC Custodian $185.22K 20.04% 2026-03-31
4 CITADEL ADVISORS LLC Custodian $80.70K 8.73% 2026-03-31
5 SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian $68.80K 7.44% 2026-03-31
6 JANE STREET GROUP, LLC Custodian $56.89K 6.16% 2026-03-31
7 GROUP ONE TRADING LLC Custodian $11.91K 1.29% 2026-03-31
5 filers$2.09M notional
# Filer Notional Value % of Total Period
1 JANE STREET GROUP, LLC Custodian $1.25M 59.67% 2026-03-31
2 CITADEL ADVISORS LLC Custodian $571.10K 27.31% 2026-03-31
3 SIMPLEX TRADING, LLC Custodian $127.01K 6.07% 2026-03-31
4 GROUP ONE TRADING LLC Custodian $75.41K 3.61% 2026-03-31
5 SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian $69.68K 3.33% 2026-03-31
Insider Activity
Latest: 2026-04-27
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-04-27 Robert N Fried Chief Executive Officer Exer (M) +20,000 $2.61 $52.2K EDGAR
2026-02-24 Ozan Pamir Chief Financial Officer Grant (A) +62,131 opt EDGAR
2026-02-24 Carlos Luis Lopez SVP, General Counsel Grant (A) +41,420 opt EDGAR
2026-02-24 Robert N Fried Chief Executive Officer Grant (A) +503,937 opt EDGAR
2025-11-17 Ozan Pamir Chief Financial Officer Buy (P) +6,685 $6.82 $45.6K EDGAR
2025-07-03 Hamed Shahbazi Director Grant (A) +20,000 opt EDGAR
2025-06-26 Kristin Patrick Director Grant (A) +20,000 opt EDGAR
2025-06-26 Wing Tak Wendy YU Director Grant (A) +20,000 opt EDGAR
2025-06-25 Frank L Jr Jaksch Director Grant (A) +20,000 opt EDGAR
2025-06-25 Wang Yu Gary Ng Director Grant (A) +20,000 opt EDGAR
2025-06-25 Ann Cohen Director Grant (A) +20,000 opt EDGAR
2025-06-25 Steven D Rubin Director Grant (A) +20,000 opt EDGAR
2025-04-09 Robert N Fried Chief Executive Officer Exer (M) +66,667 $3.30 $220.0K EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
Insider Holdings
2 insiders · @ $3.42
Officers, directors, and 10%+ owners ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Robert N Fried Chief Executive Officer 1,153,982 $3.95M $0 3 2026-04-27
2 Ozan Pamir Chief Financial Officer 9,592 $32.8K $45.6K 2 2026-02-24
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
Notice of Proposed Sale (Form 144)
Latest: 2024-12-13
Last 30d: 0 filings  ·  Last 90d: 0 filings

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. Amendments (Form 144/A) and post-cancellation refilings can inflate this if you sum naively; the rollup above excludes filings with zero stated value.

Source & freshness: Parsed directly from EDGAR primary-doc XML. Daily refresh; new filings typically appear here the morning after they hit EDGAR.

Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2024-12-13 Frank Jaksch Jr. affiliate 37,161 $230.0K 2024-12-13 Global Shares Financial Services… EDGAR
2024-08-23 Kristin Patrick affiliate 23,000 $84.8K 2024-08-23 Global Shares Financial Services… EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed.
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

P/E Ratio16.2
P/B Ratio3.2
P/S Ratio2.0
EV/EBITDA14.1
TTM Revenue$0.1B
TTM Net Income$0.0B
TTM EPS$0.21
ROE22.6%